Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Maculopathy,Age-related”

Showing 20 of 0 results

Not applicableLooking for participantsNCT07015034
What this trial is testing

Developing and Testing a Model to Identify Preventive Vision Loss Among Older Patients in General Practice

Who this might be right for
Vision Impairment and BlindnessGlaucomaAge-Related Macular Degeneration+2 more
University of Copenhagen 460
Testing effectiveness (Phase 2)Study completedNCT05562219
What this trial is testing

QA108 Phase II Study in Subjects With Intermediate Age-Related Macular Degeneration

Who this might be right for
Intermediate Age-Related Macular Degeneration
Smilebiotek Zhuhai Limited 120
Not applicableActive Not RecruitingNCT06015633
What this trial is testing

Ocular, Vascular, and Genetic Findings in AMD Patients

Who this might be right for
Age-Related Macular Degeneration
OcuDyne, Inc. 50
Testing effectiveness (Phase 2)Looking for participantsNCT07630649
What this trial is testing

Ixoberogene Soroparvovec (Ixo-vec) Contralateral Dosing Study in Participants With Neovascular Age-related Macular Degeneration

Who this might be right for
Neovascular Age-Related Macular Degeneration (nAMD) Wet AMD
Adverum Biotechnologies, Inc. 15
Not applicableStudy completedNCT04988178
What this trial is testing

Analysis of naïve Patients With Age-related Macular Degeneration Neovascular Type and Treated With Ranibizumab (Lucentis®) in Treat-and-extend at the CHU Brugmann.

Who this might be right for
Macular Degeneration
Brugmann University Hospital 34
Testing effectiveness (Phase 2)Study completedNCT01136252
What this trial is testing

Intravitreal Adalimumab in Patients With Choroidal Neovascularization Secondary to Age-related Macular Degeneration

Who this might be right for
Age-Related Macular DegenerationChoroidal Neovascularization
Hospital Universitari Vall d'Hebron Research Institute 5
Not applicableStudy completedNCT01933152
What this trial is testing

Study to Assess the EffectiVeness of exIsting Anti-vascular Endothelial groWth Factor (Anti-VEGF) Treatment Regimens in Patients With Wet Age-related Macular Degeneration

Who this might be right for
Macular Degeneration
Bayer 137
Not applicableEnded earlyNCT02137915
What this trial is testing

Long-Term Follow-up Safety Study of Human Central Nervous System Stem Cells in Subjects With Geographic Atrophy of Age-Related Macular Degeneration

Who this might be right for
Age-Related Macular DegenerationGeographic Atrophy
StemCells, Inc. 8
Testing effectiveness (Phase 2)Study completedNCT04126317
What this trial is testing

Safety, Tolerability, and Efficacy of Aflibercept in Patients With Neovascular Age-Related Macular Degeneration

Who this might be right for
Neovascular (Wet) Age-Related Macular Degeneration
Regeneron Pharmaceuticals 106
Testing effectiveness (Phase 2)Active Not RecruitingNCT06196840
What this trial is testing

Safety and Efficacy of LX102 Gene Therapy in Patients With Neovascular Age-related Macular Degeneration (nAMD) (VENUS)

Who this might be right for
Neovascular Age-Related Macular Degeneration
Innostellar Biotherapeutics Co.,Ltd 50
Testing effectiveness (Phase 2)Ended earlyNCT02214628
What this trial is testing

Phase 2A Open Label Safety Study of Fovista® (Anti-PDGF BB) Regimen Administered in Combination With Anti-VEGF Therapy to Study Sub-Retinal Fibrosis in Neovascular AMD

Who this might be right for
Age-related Macular Degeneration
Ophthotech Corporation 101
Large-scale testing (Phase 3)Ended earlyNCT02745119
What this trial is testing

Long-Term Safety of Lampalizumab Intravitreal (ITV) Injections in Participants With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (OMASPECT)

Who this might be right for
Geographic Atrophy
Hoffmann-La Roche 994
Large-scale testing (Phase 3)Not Yet RecruitingNCT05251636
What this trial is testing

Adjunct Episcleral Brachytherapy for PCV

Who this might be right for
Age-Related Macular DegenerationPolypoid Choroidal Vasculopathy
Salutaris Medical Devices, Inc. 159
Not applicableStudy completedNCT03148249
What this trial is testing

A Trial of Patients With a Charles Bonnet Syndrome

Who this might be right for
Prevalence, Psychiatrist Intervention
Vienna Institute for Research in Ocular Surgery 34
Not applicableEnded earlyNCT00444249
What this trial is testing

Influence of Blue Light Filtering Intraocular Lenses on Daytime Levels of Melatonin

Who this might be right for
Macular Degeneration
The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery 136
Large-scale testing (Phase 3)Study completedNCT02243878
What this trial is testing

Stereotactic Radiotherapy for Wet AMD (STAR)

Who this might be right for
Neovascular (Wet) Age-related Macular Degeneration (AMD)
King's College Hospital NHS Trust 411
Testing effectiveness (Phase 2)Study completedNCT05141994
What this trial is testing

Clinical Study on the Efficacy and Safety of BAT5906 Injection

Who this might be right for
Wet Age-related Macular Degeneration
Bio-Thera Solutions 48
Not applicableUnknownNCT02136303
What this trial is testing

Regional Kale as Source of Lutein and Zeaxanthin to Improve Vision of AMD-patients

Who this might be right for
Changes in Macular Pigment Optical Density
University of Jena 90
Testing effectiveness (Phase 2)UnknownNCT03594461
What this trial is testing

Intense Treatment Regimen With Intravitreal Aflibercept Injection

Who this might be right for
Neovascular Age-Related Macular Degeneration
Vitreous -Retina- Macula Consultants of New York 30
Early research (Phase 1)Study completedNCT04744662
What this trial is testing

ONL1204 Ophthalmic Solution in Patients With Geographic Atrophy Associated With Age-related Macular Degeneration

Who this might be right for
Geographic Atrophy
ONL Therapeutics 28
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation